Byooviz

Byooviz is a biologic medication used for intravitreal administration to treat certain eye conditions. It contains ranibizumab, a protein designed to inhibit vascular endothelial growth factor (VEGF).

Byooviz is primarily used for the treatment of neovascular (wet) age-related macular degeneration (AMD), a condition that can lead to vision loss. It may also be used for other eye conditions involving abnormal blood vessel growth. Byooviz works by blocking VEGF, which can help reduce swelling and prevent further damage to the retina.

Byooviz is designed to target and inhibit VEGF, which can help reduce abnormal blood vessel growth in the eye. This may lead to improved vision or stabilization of vision in certain eye conditions. Common effects may include reduced retinal swelling and improved retinal function.

Byooviz should be administered by a healthcare professional experienced in intravitreal injections. It is important to follow all safety guidelines and monitor for any signs of infection or inflammation. Patients should discuss any pre-existing conditions or allergies with their healthcare provider before treatment.

Byooviz may interact with other medications, particularly those that affect the immune system or blood vessels. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements may also interact with Byooviz, so it is advisable to discuss these with your healthcare provider.